Document 854QgD6ZOXqGywJOXR8w5y3Qe

CTFA Representing thepersonal careproducts industry E. Edward Kavandugh President VIA FACSIMILE & 0.8. MAIL October 18, 1993 Dr. Alfred P. Wehnr Biomedical & Environmental Consultants, Inc. 312 Saint Street Richland, W 99352 Dr. Wehner, The purpose of this letter is to authorize prparation of a manuscript based upon the review by Dr. Gross on the epidemiology Of talc and ovarian cancer prepared as part of the report to CTFA by Biomedical and Environmental Consultants, Inc. in September, 1992. CTFA would, however, like to review the document prior to it's submission for publication. Furthermore, this letter authorizes you to rference the BEC report to CTFA in any review Of the literature on talc you may be preparing for Johnson & Johnson. Should you have any questions, please do not hesitate to contact me (I look forward to actually meeting you, perhaps at the ISRTP Symposium on talc in January, 1994!). Sincerely, Stephen js^Ggiltings, Ph.D., D.A.B-T. Director, TOxicology H:\sdg\talc\corresp\1993-6 The Cosmetic, Toiletry, and Fragrance Association 1101 17th S tm t, N .W . Suite 300 Washington, D .C . 20036-4702 (2 0 2) 331-1770 Fax (2 0 2) 331-1969 Protected Document - Subject to Protective Order 1 of 4 PCPC0080613 Pltf PCPC 00002276 CT FA Representing thepersonal careproducts industry MEMORANDUM E. Edward Kavanaugh President DATE: TO: FROM: SUBJ : iMSeptember 28, 1993 Sallie Carr (ISRTP) Steve Gettings (CTFA) Talc Symposium Sallie: Here are the three names and addresses etc you need from me: (1) Bruce Semple, M.D. Medical Director Beauty Care Products World-Wide The Procter & Gamble Company Sharon Woods Technical Center 11511 Reed Hartman Highway Cincinnati, OH 45241 Telephone: (513) 626-0455 FAX: (513) 626-2977 (2) Guenter Oberdoerster, DVM, Ph.D. Dept, of Environmental Medicine University of Rochester 575 Elmwood Avenue, Box EHSC Rochester, NY 14642 Telephone: (716) 275-3874 FAX: (716) 256-2631 (3) Robert J. Piniazkiewicz Luzenac America, Inc. P.O. Box 939 Ennis, MT 59729 Telephone: (406) 682-4882 FAX: (406) 682-4307 All three have agreed to participate. H:\sdg\talc\corresp\1993-5 The Cosmetic, Toiletry, and Fragrance Association 1101 17th Street, N .W . Suite 300 Washington, D .C . 20036-4702 (2 0 2 ) 331-1770 Fax (202) 331-1969 Protected Document - Subject to Protective Order 2 of 4 PCPC0080614 Pltf PCPC 00002276 CT F A Representing thepersonal careproducts industry n . E dw ard Kavanaugh President August 16, 1993 C. Jelleff Carr, Ph.D. International Society of Regulatory Toxicology and Pharmacology 6546 Belleview Drive Columbia, MD 21046-1054 Dear Jelleff, Thank you for your letter of July 21st. I too enjoyed our meeting in Aspert and I look forward to continuing to work with you on the tale issue. I was so impressed with the Society's handling of the MGS issue last November, and now with its role in re-assuring FDA of the safety of Talc, that I have decided to join ISRTP. My application is enclosed. Best regards, Enclosure H:\sdg\talc\corresp\1993^4 The Cosmetic, Toiletry, and Fragrance Association 1101 17th Street, N .W . Suite 300 Washington, D .C . 20036-4702 (2 0 2 ) 331-1770 Fax (202) 331-1969 Protected Document - Subject to Protective Order 3 of 4 PCPC0080615 Pltf PCPC 00002276 CT FA Representing thepersonal careproducts industry . EdwaPrredsiKdeanvtanaugh July 27, 1993 Don Hughes, Ph.D. The Procter & Gamble Company P.0. Box 398707 Cincinnati, OH 45239-8707 Dear Don, Further to our conversation in Aspen, I am forwarding you a copy of the report prepared for CTFA summarizing safety issues related to Talc. Pleafe feel free to distribute this report to other members of the ISRTP Planning Committee. Sincerely, Stephen Dir Gettings, Ph.D*, D.A.B.T. Directo**, Toxicology Enclosure H:\sdg\talc\corresp\1993-3 The Cosmetic, Toiletry, and Fragrance Association 1101 17th Street, N .W . Suite 300 Washington, D .C . 20036-4702 (2 0 2) 331-1770 Fax (2 0 2) 331-1969 Protected Document - Subject to Protective Order 4 of 4 PCPC0080616 Pltf PCPC 00002276